Chemoinformaics analysis of benzyl 6-O- á-L-rahamnopyranosyl-b-D-glucopyranoside
| Molecular Weight | 97.015 | nRot | 0 |
| Heavy Atom Molecular Weight | 97.015 | nRig | 1 |
| Exact Molecular Weight | 96.9901 | nRing | 0 |
| Solubility: LogS | -0.385 | nHRing | 0 |
| Solubility: LogP | 0.367 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 6 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 0 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 5.813 |
| nHD | 0 | BPOL | 4.207 |
| QED | 0.434 |
| Synth | 3.395 |
| Natural Product Likeliness | -0.56 |
| NR-PPAR-gamma | 0.023 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.401 |
| MDCK | 0.0000238 |
| BBB | 0.908 |
| PPB | 0.404443 |
| VDSS | 1.941 |
| FU | 0.612514 |
| CYP1A2-inh | 0.343 |
| CYP1A2-sub | 0.847 |
| CYP2c19-inh | 0.109 |
| CYP2c19-sub | 0.807 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.295 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.29 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.268 |
| CL | 7.832 |
| T12 | 0.625 |
| hERG | 0.02 |
| Ames | 0.805 |
| ROA | 0.948 |
| SkinSen | 0.869 |
| Carcinogencity | 0.76 |
| EI | 0.979 |
| Respiratory | 0.983 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.933 |